[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 474,342
  • Shares Outstanding, K 41,319
  • Annual Sales, $ 292,500 K
  • Annual Income, $ -33,990 K
  • EBIT $ -25 M
  • EBITDA $ 1 M
  • 60-Month Beta 0.37
  • Price/Sales 1.67
  • Price/Cash Flow 24.21
  • Price/Book 2.80

Options Overview Details

View History
  • Implied Volatility 83.13% (+11.89%)
  • Historical Volatility 30.92%
  • IV Percentile 92%
  • IV Rank 66.02%
  • IV High 106.24% on 07/14/25
  • IV Low 38.24% on 10/23/25
  • Expected Move (DTE 18) 1.59 (13.85%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 790
  • Open Int (30-Day) 2,163
  • Expected Range 9.89 to 13.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/26
See More
  • Average Estimate $-0.11
  • Number of Estimates 2
  • High Estimate $-0.07
  • Low Estimate $-0.15
  • Prior Year $-0.03
  • Growth Rate Est. (year over year) -266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.65 +7.79%
on 05/19/26
12.20 -5.90%
on 05/27/26
+0.82 (+7.69%)
since 04/29/26
3-Month
9.39 +22.26%
on 04/07/26
12.20 -5.90%
on 05/27/26
+0.04 (+0.35%)
since 02/27/26
52-Week
8.36 +37.32%
on 08/08/25
13.99 -17.94%
on 12/04/25
+1.22 (+11.89%)
since 05/28/25

Most Recent Stories

More News
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect

Palmetto GBA Medicare Coverage Effective July 5, 2026 Advances NanoKnife IRE Reimbursement Access in Prostate and Liver Cancer, Building on Category I CPT Codes Toward Broader National Payer Coverage

ANGO : 11.48 (-2.63%)
AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.48 (-2.63%)
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer

Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 months Results Presented at AUA 2026

ANGO : 11.48 (-2.63%)
AngioDynamics: Fiscal Q3 Earnings Snapshot

AngioDynamics: Fiscal Q3 Earnings Snapshot

ANGO : 11.48 (-2.63%)
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

Med Tech segment delivered its sixth consecutive quarter of double-digit growth Strong adjusted EBITDA Third consecutive quarter the Company raised full year FY 2026...

ANGO : 11.48 (-2.63%)
AngioDynamics Reports Tomorrow But the Guidance Will Matter More Than the Quarter

Barchart Research What to Expect from ANGO Earnings ANGO Generated April 1, 2026 Current Price $11.94 EPS Estimate $$-0.11 Consensus Rating Strong Buy Average Move 16.42% AngioDynamics Reports Tomorrow...

ANGO : 11.48 (-2.63%)
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.48 (-2.63%)
U.S. Jobs Figures Issued in Short Week

MondayFeatured Earnings Maze Therpautics (NASDAQ:MAZE) (Q4) EPS for loss of 73 cents, compared ...

AYI : 305.11 (+1.60%)
MKC : 47.37 (+1.15%)
FDS : 245.47 (+3.25%)
MSM : 109.47 (-0.28%)
CAG : 13.28 (-0.75%)
NKE : 46.23 (-2.41%)
PRGS : 32.83 (+7.50%)
POET : 12.29 (-7.32%)
LW : 43.18 (-0.80%)
ANGO : 11.48 (-2.63%)
MAZE : 26.46 (+0.23%)
LNN : 109.29 (-0.66%)
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.48 (-2.63%)
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.48 (-2.63%)

Business Summary

AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies...

See More

Key Turning Points

3rd Resistance Point 12.06
2nd Resistance Point 11.93
1st Resistance Point 11.71
Last Price 11.48
1st Support Level 11.36
2nd Support Level 11.23
3rd Support Level 11.01

See More

52-Week High 13.99
Fibonacci 61.8% 11.84
Last Price 11.48
Fibonacci 50% 11.17
Fibonacci 38.2% 10.51
52-Week Low 8.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.